Tzamaloukas A H, Murata G H, Malhotra D, Rao P, Piraino B, Bernardini J, Oreopoulos D G
Albuquerque Veterans Affairs Medical Center, New Mexico, USA.
Adv Perit Dial. 1999;15:179-82.
Normalized clearances for urea and creatinine were compared between 121 diabetic subjects (256 clearances) and 181 nondiabetic subjects (357 clearances) on continuous ambulatory peritoneal dialysis (CAPD) with four 2-L exchanges daily. Urea clearance was normalized by VWatson (Kt/Vur), while creatinine clearance was normalized by both VWatson (Kt/Vcr) and body surface area (Ccr). Height, weight, body water (V), and body surface area did not differ between the diabetic and the nondiabetic groups. Also, renal Kt/Vur, renal Kt/Vcr, renal Ccr, and peritoneal Kt/Vur did not differ between the groups. Weekly peritoneal Kt/Vcr (diabetic group 1.36 +/- 0.38, nondiabetic group 1.31 +/- 0.31, p = 0.048) and weekly peritoneal Ccr (diabetic group 47.6 +/- 11.0 L/1.73 m2, nondiabetic group 45.4 +/- 9.2 L/1.73 m2, p = 0.012) were both higher in diabetic subjects. The percentage of high/high-average transporters was higher in the diabetic group (64.9% vs 48.6% in nondiabetic group, p = 0.006). The following total (peritoneal + renal) weekly clearances were obtained: Kt/Vur, diabetic group 2.07 +/- 0.63, nondiabetic group 2.02 +/- 0.56, NS; Kt/Vcr, diabetic group 2.06 +/- 0.78, nondiabetic group 1.92 +/- 0.74, p = 0.026; Ccr, diabetic group 72.7 +/- 28.5 L/1.73 m2, nondiabetic group 67.2 +/- 26.4 L/1.73 m2, p = 0.013. Normalized total creatinine clearances are higher in diabetic subjects than nondiabetic subjects on the same CAPD schedule and with the same renal clearances of urea and creatinine and the same total Kt/Vur, because peritoneal creatinine clearances are higher in the diabetic subjects. This finding is caused by higher peritoneal transport in the diabetic subjects and is not an artifact caused by the normalization process.
在121例糖尿病患者(256次清除率)和181例非糖尿病患者(357次清除率)中,比较了每日进行4次2L交换的持续非卧床腹膜透析(CAPD)时尿素和肌酐的标准化清除率。尿素清除率通过VWatson法标准化为(Kt/Vur),而肌酐清除率通过VWatson法(Kt/Vcr)和体表面积(Ccr)进行标准化。糖尿病组和非糖尿病组的身高、体重、身体水分(V)和体表面积无差异。此外,两组之间的肾脏Kt/Vur、肾脏Kt/Vcr、肾脏Ccr和腹膜Kt/Vur也无差异。糖尿病患者的每周腹膜Kt/Vcr(糖尿病组1.36±0.38,非糖尿病组1.31±0.31,p = 0.048)和每周腹膜Ccr(糖尿病组47.6±11.0 L/1.73 m2,非糖尿病组45.4±9.2 L/1.73 m2,p = 0.012)均较高。糖尿病组中高/高平均转运体的百分比更高(糖尿病组为64.9%,非糖尿病组为48.6%,p = 0.006)。获得了以下总的(腹膜+肾脏)每周清除率:Kt/Vur,糖尿病组2.07±0.63,非糖尿病组2.02±0.56,无显著差异;Kt/Vcr,糖尿病组2.06±0.78,非糖尿病组1.92±0.74,p = 0.026;Ccr,糖尿病组72.7±28.5 L/1.73 m2,非糖尿病组67.2±26.4 L/1.73 m2,p = 0.013。在相同的CAPD方案、相同的尿素和肌酐肾脏清除率以及相同的总Kt/Vur情况下,糖尿病患者的标准化总肌酐清除率高于非糖尿病患者,因为糖尿病患者的腹膜肌酐清除率更高。这一发现是由糖尿病患者较高的腹膜转运所致,而非标准化过程造成的假象。